Download Curriculum Vitae: Rachel Lampert

Curriculum Vitae: Rachel Lampert
Address:
home:
43 Linden Ave
Branford, CT 06405
phone: (203) 488-4946
Section of Cardiology, Yale University School of Medicine
333 Cedar Street, FMP 3
New Haven, CT 06520
phone (203) 737-4068
work:
Birthdate:
September 26, 1961
Education:
Phillips Academy 1979
Andover, MA
Harvard College BA, 1983
Cambridge, MA
Vanderbilt Medical School MD, 1987
Nashville, TN
Post Graduate Experience
July ‘87-June ‘88: Intern, Internal Medicine
Bellevue/New York University Medical Center; New York, NY
July ‘88-June’90: Resident, Internal Medicine
Bellevue/ New York University Medical Center
July ‘90-June ‘91: Chief Resident, Internal Medicine
Bellevue/New York University Medical Center
July ‘91-July ‘92: Visiting physician/professor
Hospital-Escuela Oscar Danilo Rosales A.
Universidad Nacional Autonoma de Nicaragua; Leon, Nicaragua
July ‘92-June '96: Clinical Fellow, Section of Cardiovascular
Medicine, Yale-New Haven Hospital; New Haven, CT
Employment
July ‘96-June ‘97 Clinical Instructor of Medicine,
July ‘97-June ‘01 Assistant Professor of Medicine
July ‘01-June ‘03 Associate Research Scientist
July ’03-June ‘05 Assistant Professor of Medicine
July ’05-present Associate Professor of Medicine
Section of Cardiovascular Medicine
Yale School of Medicine, New Haven, CT
Certifications:
National Board of Medical Examiners 1988
American Board of Internal Medicine 1990
ABIM, Cardiovascular Diseases 1995, 2005
ABIM, Clinical Cardiac Electrophysiology, 1998, 2008
Memberships:
Fellow, American College of Cardiology
Fellow, Heart Rhythm Society
Grant Review Committees:
American Heart Association, National: Electrophysiology and
Arrhythmias, spring 2004-fall 2007
AHA, Heritage Affiliate: Clinically Applied Research, spring 2004, spring 2006
AHA, Region I: Electrophysiology and Arrhythmias, Co-Chair, 2007-08
Chair, 2008-2010
CT CASE-DPH reviewer spring 2009, spring 2010, fall 2011, fall 2012
FDA Office of Women’s Health, ad hoc reviewer spring 2007
National Institute of Health, MESH, February 10-11, 2005
NIH, 2008/10 ZRG1 CVS-K (10) B - Cardiovascular Sciences Small Business
Activities, primary reviewer, spring 2008, fall 2008
NIH ARRA SEPs: ZHL1 CSR-G 02, and ZHL CSR-U(02) , summer 2009
NIH ZHL1 CSR-G F1 1, (ancillary studies) fall 2009, spring 2010, summer 2010,
fall 2010
NIH, CICS, spring 2010, fall 2010, appointed standing member spring 2011
Other National Committees: Heart Rhythm Society, Scientific and Clinical Documents Committee,
Spring 2005-2012, Vice-Chair, spring 2007-08, Chair, spring 2008-2012
Heart Rhythm Society Task Force for Device Performance, 7/05-10/06; Task force
For Lead Performance, 4/08-5/09; Task Force for Device Deactivation at End of
Life, Co-Chairman, 10/08-6/10; Task Force on Relationships with Industry, 9/105/11
Heart Rhythm Society, Board of Trustees, spring 2010-spring 2013
Heart Rhythm Society, Women’s Leadership Initiative, 3/07-present
Heart Rhythm Society, Ethics Committee, 5/12-present
American College of Cardiology, ICD Registry Research and Publications
Committee, spring 2007-spring 2013
American College of Cardiology, Scientific Sessions Program Committee (Sports
Council), 2012
Journal Peer Reviewer: J Am Coll Cardiol (Elite Reviewer), Circulation, American Journal of
Cardiology, PACE, Psychosomatic Medicine, American Heart Journal, J
Psychosomatic Research, Journal Cardiovascular Electrophysiology, Heart
Rhythm
Editorial Board, Psychosomatic Medicine, spring 2010-present
J Am Coll Cardiol, 10/10-present
ACC Cardiosource Cardiac Rhythm Management Online Community, Editor-in-Chief, spring 2012present
Abstract reviewer: American Heart Association 2009, 2010, 2011, 2012
Data Safety and Monitoring Board: Pulse Study, NIH NHLBI (R01 HL081642), PI Funk
Modeling Stress-precipitated Smoking Behavior for Medication Development”, McKee SCOR
Hospital committees:
HVC quality committee
Intern selection committee
CTSA Science and Safety Committee
CTSA biomedical informatics advisory board
Publications
1) Published papers in peer-reviewed journals
1. Lampert R, Rosenfeld L, Batsford W, Lee F, McPherson C: Circadian Variation of Sustained
Ventricular Tachycardia in Patients with Coronary Artery Disease and Implantable CardioverterDefibrillators. Circulation 1994; 90:241-247.
2. Lampert R, Rosenfeld L, McPherson C, Lewis R, VanZetta A, Batsford W: Initial Single-Center
Experience with an Advanced Third Generation Investigational Defibrillator. PACE 1996; 19:20722082
3. Lampert R, McPherson CA, Lewis RJ, Batsford WP, Rosenfeld LE: Inappropriate Sensing of Atrial
Stimuli in Patients with a Third Generation Defibrillator and DDD Pacemaker. PACE 1998; 21: 12251229
4. Lampert R, Jain D, Burg M, Batsford W, McPherson C: Destabilizing effects of mental stress on
ventricular arrhythmias in patients with Implantable Cardioverter-defibrillators. Circulation 2000;
101:158-164
5. Jain D, Joska T, Lee F, Burg M, Lampert R, Zaret B: Day to Day Reproducibility of Mental Stress
Induced Left Ventricular Dysfunction in Patients With Coronary Artery Disease and its Relationship to
Autonomic Activation. Journal of Nuclear Cardiology; 2001; 8:347-55.
6. Lampert R, Baron S, McPherson C, Lee F: Heart Rate Variability During the Week of September 11,
2001. JAMA, 2002; 288: 575.
7. Lampert R, Joska T, Burg M, Batsford WP, McPherson CA, Jain D: Emotional and Physical
Precipitants of Ventricular Arrhythmia. Circulation 2002; 106: 1800-1805
8. Lampert R, Ickovics JR, Viscoli CJ, Horwitz RI, Lee FA: Effects of Propranolol on Recovery of
Heart Rate Variability Following Acute Myocardial Infarction and Relation to Outcome in the BetaBlocker Heart Attack Trial. Am J Cardiol 2003;91 :137-142
9. Koul AK, Keller S, Clancy JF, Lampert R, Batsford WP, Rosenfeld LE. Hyperkalemia induced T
wave oversensing leading to loss of bi-ventricular pacing and inappropriate ICD shocks. PACE; 27:
681-683, 2004.
10. Lampert R, McPherson CA, Clancy JF, Caulin-Glaser T, Rosenfeld LE, Batsford, WP: Gender
Differences in Ventricular Arrhythmia Recurrence in Patients with Coronary Artery Disease and
Implantable Cardioverter Defibrillators. J Am Coll Cardiol 2004; 43/12: 2293-2299
11. Schreibman, Rosenfeld, McPherson, Batsford, Lampert: Usefulness of Procainamide Challenge for
Electrophyiologic Arrhythmia Risk Stratification. Am J Cardiol, 2004; 94:1435-1438.
12. Burg, M, Lampert, R, Joska, T, Batsford, W, Jain, D. Psychological Traits and Emotion-triggering
of ICD Shock-terminated Arrhythmias. Psychosomatic Medicine, 2004;66:898-902.
13. Lampert, R, Ickovics, J, Horwitz, R. Lee, F.: Depressed Autonomic Nervous System Function in
African-Americans and Individuals of Lower Social Class: A Potential Mechanism of Race and ClassRelated Disparities in Health Outcomes. Am Heart J 2005; 150:153-60
14. Goldstein, NE, Lampert, R, Bradley, E, Lynn, J, Krumholz, HM: Management of CardioverterDefibrillators in End-of-Life Care. Annals Intern Med 2005; 141:835-838.
15. Lampert, R, Shusterman, V, Burg, M, Lee, F, Earley, C, Goldberg, A, McPherson, C, Batsford, W,
Soufer, R: Effects of Psychologic Stress on Repolarization and Relationship to Autonomic and
Hemodynamic Factors. J Cardiovasc Electrophysiology; 2005; 16: 372-377.
16. Whang , W, Albert, C, Sears, S, Lampert, R, Conti, J, Wang, P, Singh, J, Ruskin, J, Muller, J,
Mittleman, M, for the TOVA investigators: Depression as a Predictor for Appropriate Shocks among
Patients with Implantable Cardioverter-Defibrillators: Results from the Triggers of Ventricular
Arrhythmias (TOVA) Study. J Am Coll Cardiol, 2005; 45:1090-1095
17. Davids JS. McPherson CA. Earley C. Batsford WP. Lampert R. Benefits of cardiac rehabilitation in
patients with implantable cardioverter-defibrillators: a patient survey. Archives of Physical Medicine &
Rehabilitation, 2005. 86:1924-8
18. Goldberger, Z, Elbel, B, McPherson, C, Paltiel, AD, Lampert R. Cost Advantage of Dual versus
Single Chamber Cardioverter Defibrillator Implantation. J Am Coll Cardiol, 2005; 46:850-7.
19. Lampert, R, Cannom, D, Olshansky, B. Safety of Sports in Patients with Implantable Cardioverterdefibrillators: A Survey of Heart Rhythm Society Members. J Cardiovasc Electrophysiol, 2006; 17:1-5.
20. Shah, R, Burg, M, Vashist, A, Collins, D, Liu, J, Jadbabie, F, Graeber, B, Earley, C, Lampert, R,
Soufer, R. C-Reactive Protein and Vulnerability to Mental-Stress-Induced Myocardial Ischemia.
Molecular Medicine, 2006;12:269-274
21. Stopper, M,Joska, T, Burg, M, Batsford, W, McPherson, C, Jain, D, Lampert, R. Electrophysiologic
Characteristics of Anger-triggered Arrhythmias. Heart Rhythm, 2007; 4:268-73.
22. Dewland, T, Androne, A, Lee, F, Lampert, R, Katz, S. Effect of Acetylcholinesterase Inhibition with
Pyridostigmine on Cardiac Parasympathetic Function in Sedentary Adults and Trained Athletes.
American Journal of Physiology - Heart & Circulatory Physiology, 2007, 293:H86-92.
23. Lampert, R, Soufer, R, McPherson, CA, Batsford, WP, Tirado, S, Earley, C, Goldberg, A,
Shusterman, V. Implantable cardioverter-defibrillator shocks increase T-wave alternans. J Cardiovasc
Electrophysiol, 2007: 18:512-517
24. Vaccarino V, Lampert R, Bremner JD, Lee FA, Su S, Maisano C, Murrah NV, Jones L, Jawed F,
Afzal N, Ashraf A, Goldberg J: Depressive symptoms and heart rate variability: Evidence for a shared
genetic substrate in a study of twins. Psychosom Med, 2008: 70:628-636
25. Lampert, R, Bremner, JD, Su, Shaoyong, Miller, A,Lee, F, Cheema, F, Goldberg, J, Vaccarino, V:
Decreased heart rate variability is associated with higher levels of inflammation in middle-aged men.
American Heart Journal, 2008: 156(4): 759.e1–759.e7
26. Hauser, RG, Maron, BJ, Marine, JE, Lampert, R, Kadish, A, Winters, S, Scher, DL, Biria, M, Kalia,
A: Safety and efficacy of high voltage implantable cardioverter defibrillator leads in high-risk
hypertrophic cardiomyopathy patients. Heart Rhythm, 2008:1517-22.
27. Gehi, A, Lampert, R, Veledar, E, Lee, F, Goldberg, J,; Jones, L, Murrah, N,; Ashraf, A, Vaccarino,
V: A Twin Study of Metabolic Syndrome and Autonomic Tone. J Cardiovasc Electrophysiol, 2009:
422-8
28. Lampert, R., Shusterman, V, Burg, M, Batsford, W, McPherson, C, Soufer, R.: Anger-induced Twave alternans predicts future ventricular arrhythmias in patients with implantable cardioverterdefibrillators, JACC, 2009: 53:774-8
29. Curtis, JP, Luebbert, J, Wang, Y, Rathore, SS, Chen, J, Heidenreich, PA, Hammill, SC, Lampert, R,
Krumholz, HM: Association of physician certification and outcomes among patients receiving an
implantable cardioverter-defibrillator. JAMA, 2009: 301:1661-1670
30. Mendu, ML, McAvay, G, Lampert, R, Stoehr, J, Tinetti, M:
Yield of Diagnostic Tests in
Evaluating Syncopal Episodes in Older Patients. Archives Int Med, 2009: 169:1299-1305
31. Burg MM., Graeber B., Vashist A., Collins D., Earley C., Liu J., Lampert R., Soufer R.:
Noninvasive detection of risk for emotion-provoked myocardial ischemia.. Psychosomatic Medicine,
2009:14-20
32. Su S., Lampert R., Zhao J., Bremner JD., Miller A,. Snieder H., Lee F,. Khan D,. Goldberg J.,
Vaccarino V. : Pleiotropy of C-reactive protein gene polymorphisms with C-reactive protein levels and
heart rate variability in healthy male twins. American Journal of Cardiology, 2009: 104:1748-54
33. Donahue, RG, Lampert, R, Dornelas, E, Clemow, L, Burg, MM: Rationale and Design of a
Randomized Clinical Trial Comparing Stress Reduction Treatment to Usual Cardiac Care: The Reducing
Vulnerability to Implantable Cardioverter Defibrillator Shock-Treated Ventricular Arrhythmias
(RISTA) Trial. Psychosomatic Medicine, 2010: 72:172-77.
34. Lampert, R, Salberg, L, Burg, MM: Emotional triggering of symptoms in hypertrophic
cardiomyopathy: A survey of the Hypertrophic Cardiomyopathy Association (HCMA). PACE, 2010,
33:1047-53
35. Friedman, RSC, Burg, MM, Miles, P, Lee, F, Lampert, R: Effects of Reiki on autonomic activity
early after acute coronary syndrome. J Am Coll Cardiol, 2010:56:995-6.
36. Dai, J, Lampert, R, Wilson, PW, Goldberg, J, Ziegler, TR, Vaccarino, V: Mediterranean Dietary
Pattern Is Associated With Improved Cardiac Autonomic Function Among Middle-Aged Men: A Twin
Study. Circ Cardiovasc Qual Outcomes 3(4):366-73, 2010 Jul
37. Razak, E, Buncova, M, Shusterman, V, Winter, B, Shen, W, Ackerman, M, Donovan, T, Lampert, R,
Nemec, J. Slow QT interval adaptation to heart rate change in normal ambulatory subjects. Annals
Noninvasive Cardiology, in press
38. Su S. Lampert R. Lee F. Bremner JD. Snieder H. Jones L. Murrah NV. Goldberg J. Vaccarino V.
Common genes contribute to depressive symptoms and heart rate variability: The Twins Heart Study.
Twin Research & Human Genetics. 13(1):1-9, 2010 Feb.
39. Gravelin, LM, Yuhas, J, Remetz, M, Radford, M, Foley, J, Lampert, R: Use of a screening tool
improves appropriate referral for implantable cardioverter-defibrillators for primary prevention of
sudden cardiac death. Circ Cardiovasc Qual Outcomes, 2011. 4:152-156
40. Burg, MM, Soufer, A, Lampert, R, Collins, D: Autonomic contribution to endothelin-1 increase
during laboratory anger-recall stress in patients with coronary artery disease. Molecular Medicine, 17(56):495-501
41. Shah, AJ, Su, S, Veledar, E, Bremner, JD, Goldstein, FC, Lampert, R, Goldberg, J, Vaccarino, V:
Is heart rate variability related to memory performance in middle-aged men? Psychosomatic Medicine,
2011; 73(6):475-82
42. Abisse, SS, Lampert, R, Burg, M, Soufer, R, Shusterman, V: Cardiac repolarization instability
during psychological stress in patients with ventricular arrhythmias. J Electrocardiology, 2011. 44: 678683
43. Ashare R., Sinha R., Lampert R., Weinberger A.H., Anderson G., Lavery M., Yanagisawa, K.,
McKee S.A: Blunted vagal reactivity predicts stress-precipitated tobacco smoking.
Psychopharmacology, 220(2):259-68, 2012
44. Cheng, A, Wang, Y, Berger, RD, Calkins, H, Buxton, AE, Curtis, JP, Lampert, R:
Electrophysiology studies in patients undergoing ICD implantation: Findings from the NCDR. PACE,
2012, 35:912–918
45. Bhatt, P, Curtis, J, Wang, Y, Lampert, R: Impact of a recent lead recall on utilization of implantable
cardioverter defibrillators: Data from the NCDR ICD Registry. J Cardiovasc Electrophys 2012. 23:
861-65.
46. Yuhas, J, Mattocks, K, Gravelin, L, Remetz, M, Foley, J, Fazio, R, Lampert, R. Patient attitudes and
perceptions of implantable cardioverter-defibrillators: Potential barriers to appropriate primary
prophylaxis. PACE, 2012; 35:1179–1187
47. Dodson JA, Fried TR, Van Ness PH, Goldstein N, Lampert R. Patient Preferences for Deactivation
of Implantable Cardioverter Defibrillators. JAMA Internal Medicine. 2013 173(5):377-9 (Archives of
Internal Medicine)
48. Lampert, R; Wang, YF, Curtis, JP. Variation among hospitals in selection of higher-cost, “highertech”, implantable cardioverter-defibrillators: Data from the NCDR ICD Registry™. American Heart
Journal 2012: 165: 1015-1023.
49. Shah, AJ, Lampert, R; Goldberg, J; Veledar, E; Bremner, JD, Vaccarino, V: Posttraumatic Stress
Disorder and Autonomic Inflexibility in Male Twins. Biological Psychiatry 2013: 73: 1103-1110
50. Mandawat, A, Curtis, JP, Mandawat, A, Njike, V, Lampert, R: Safety of Pacemaker Implantation in
Nonagenarians: An Analysis of the Healthcare Cost and Utilization Project-Nationwide Inpatient
Sample. Circulation, 2013, 127(14):1453-65
51. Lampert R, Olshansky B, Heidbuchel H, Lawless C, Saarel E, Ackerman M, Calkins H, Estes NAM,
Link MS, Maron BJ, Marcus F, Scheinman M, Wilkoff BL, Zipes DP, Berul CI, Cheng A, Law I,
Loomis M, Barth C, Brandt C, Dziura J, Li F, Cannom D. Safety of sports for athletes with
implantable cardioverter-defibrillators: Results of a prospective, multinational registry.
Circulation. 2013;127:2021-2030
52. Udo, T, Weinberger, AH, Grilo, CM, Brownell, KD, DiLeone, RJ, Lampert, R, Matlin, SL,
Yanagisawa, K, McKee, SA. Heightened Vagal Activity during High-Calorie Food Presentation in
Obese compared with Non-obese Individuals - Results of a Pilot Study. Obesity Research & Clinical
Practice, 2013, in press
53. Russo, AM, Wang, Y, Curtis, J, Al-Khatib, S, Lampert, R. Contemporary Patterns of Practice
Related to Defibrillation Testing and Adverse Events during Implantable CArdioverter Defibrillator
Insertion: Analysis of the NCDR ICD Registry. PACE, 2013, in press
54. Winkler, C, Funk, M; Schindler, DM, Hemsey, JZ, Lampert,R, Drew, B. Arrhythmias in Patients
with Acute Coronary Syndrome in the First 24 Hours of Hospitalization. Heart and Lung, in press
55. Wagner, J, Lampert, R, Tennen, H, Feinn, R. Exposure to Discrimination and Heart Rate Variability
Reactivity to Acute Stress among Women with Diabetes. Stress and Health, in press
2) Reviews, Guideline documents, Editorials, Book Chapters:
1. Lampert R : Long-term management of atrial fibrillation: Maintenance of sinus rhythm
vs. rate control and anticoagulation; American Journal of Geriatric Cardiology 1998; 7:33-42.
2. Ezekowitz M, and Lampert R: Pharmacological Control of Rate and Maintenance of
Sinus Rhythm; Journal of Thrombosis and Thrombolysis 1999; 7:33-38.
3. Lampert R, Ezekowitz M: Management of Arrhythmias; In: Clinics in Geriatric Medicine.
2000;16:593-618.
4. Goldberger, Z, Lampert, R. Implantable Cardioverter-Defibrillators: Expanding Indications and
Technologies; JAMA 2006; 295:809-818.
5. Carlson, MD, Willcoff, BS, Maisel, WH, Ellenbogen, KA, Saxon, LA, Prystowsky, EN, Alpert, JS,
Cain, ME, Ching, EA, Curtis, AB, Davies, DW, Hammill, SC, Hauser, RG, Lampert, R, Zipes, DP:
Recommendations from the Heart Rhythm Society Task Force on Device Performance Policies and
Guidelines; Heart Rhythm Journal 2006; 3:1250-1273.
6. Lampert, R: Implantable Cardioverter-Defibrillator Use and Benefit in Women; Cardiology in
Review, 2007; 15: 298-303
7. Lampert, R: Atrial Fibrillation in Athletes: Toward better understanding and more effective therapy;
J Cardiovasc Electrophys, 2008; 19:463-5. (editorial)
8. Lampert R, Cannom D: Sports participation for athletes with implantable cardioverter-defibrillators
should be an individualized risk-benefit decision. Heart Rhythm 2008; 5:861-3. (“Conflicts in
cardiology” section invited editorial)
9. Maisel, WH, Hauser, RG, Hammill, SC, Ellenbogen, KA, Epstein, AE, Hayes, DL, Alpert, JS,
Berger, RD, Curtis, AB, Dubin, AM, Estes, NAM, Gura, MT, Krahn, AD, Lampert, R, Lindsay, BD,
Wilkoff, BL: Recommendations from the Heart Rhythm Society Task Force on Lead Performance
Policies and Guidelines; Heart Rhythm, 2009, 6: 869-885.
10. Lampert, R: Emotion and sudden cardiac death; Expert Review Cardiovascular Therapeutics,
2009,7:723-25
11. Shusterman, V, Lampert, R, London, B: The many faces of repolarization instability: Which one is
prognostic; J Electrocardiology, 2009, 42:511-6
12. Lampert, R: Anger and ventricular arrhythmias; Current Opinion in Cardiology, 2010, 25:46-52
13. Lampert, R and Goldberger, J: Implantable Cardioverter Defibrillators. In, Device Therapy in Heart
Failure, Editor Maisel, WH, Humana Press, p 155-185
14. Lampert, R , Hayes, DL, Annas, GJ, Farley, MA, Goldstein, NE, Hamilton, RM, Kay, GN, Kramer,
DB, Mueller, PS, Padeletti, L, Pozuelo, L, Schoenfeld, MH, Vardas, PE, Wiegand, DL, Zellner, R: HRS
Expert Consensus Statement on the Management of Cardiovascular Implantable Electronic Devices
(CIEDs) in patients nearing end of life or requesting withdrawal of therapy. Heart Rhythm, 2010;
7:1008-1026
15. Lampert, R: Air pollution and repolarization heterogeneity: More impetus for alternative energy. J
Am Coll Cardiol, 2011; 57: 207-209 (editorial)
16. Lampert, R, and Saul, P: The athlete with an implanted device: Implantable cardioverterdefibrillators and pacemakers. In, Sports Cardiology in Practice, Editor, Lawless, C, Springer,2011
17. Lampert, R: Use of antiarrhythmic medications in women. European Cardiology, 2010. 6: 70-73
18. Lampert, R: Survival of ICD patients in the era of remote-monitoring: The five- thousand foot, highAltitude view. Circulation. 2010;122:2353-2355 (editorial)
19. Padeletti, L, Arnar, David O., Boncinelli, L, Brachman, J, Camm, J., Daubert, J, Kassam, S.,
Deliens, L., Glikson, M., Dayes, D., Israel, C., Lampert, R., Lobban, T., Raatikainen, P., Siegal, G.,
Vardas, P: EHRA Expert Consensus Statement on the management of cardiovascular implantable
electronic devices in patients nearing end of life or requesting withdrawal of therapy. Europace, 2010.
12(10):1480-9, 2010 Oct
20. Lindsay, BD, Asirvatham, SJ, Curtis, AB, Gura, MT, Hayes, DL, Jalife, J, Klein, GJ, Knight, BP,
Lampert, R, Natale, A, Packer, DL, Page, RL, Scheinman, MM, Shanker, AJ, Wang, PJ, Weiss, JP,
Wilkoff, BL, Busky, CD: Guidance for the Heart Rhythm Society Pertaining to Interactions with
Industry: Endorsed by the Heart Rhythm Society on April 26, 2011, Heart Rhythm, 2011. 8: e19-e23
21. Lampert, R: Evaluation and management of arrhythmia in the athletic patient. Progress in
Cardiovascular Diseases, 2012. 54: 423-431.
22. Lampert, R, Olshansky, B: Sports participation in patients with implantable cardioverter–
defibrillators. Herzschrittmachertherapie + Elektrophysiologie, 2012, 23:87–93
23. Lampert, R: Put on a Happy Face—It’s a Lot Better than Coumadin; JAHA, 2012, in press
(editorial)
24. Lampert, R: Primary prevention ICDs—They work in the real world too. Circulation: Arrhythmias
and Electrophysiology, 2012; 5: 624-625 doi: 10.1161/CIRCEP.112.974907 (editorial)
25. Lampert, R and Hayes, D. Ethical issues in pacemaker and implantable cardioverter-defibrillator
therapy. In, Clinical Cardiac Pacing, Defibrillation, and Resynchronization Therapy, Ed Ellenbogen,
Kay, Lau, and Wilkoff; Elsevier, 2011 (book chapter)
26. Lampert, R: Quality of Life and End-Of-Life Issues for Older Patients with Implanted Cardiac
Rhythm Devices. In, Clinics in Geriatric Medicine: Cardiac Rhythm Disorders in Older Adults, 2012, p
693-702.
27. Corrine Jurgens, Sarah Goodlin, Mary Dolansky, Ali Ahmed, Ross Arena, Lenore Blank, Harleah
Buck, Kerry Cranmer, Gregg Fonarow, Rebecca Boxer, Jerome Fleg, Rachel Lampert, Terry Lennie,
JoAnn Lindenfeld, Ileana Pina, Todd Semla, Patricia Trebbien, and Michael Rich: Heart Failure
Management in Skilled Nursing Facilities, Circulation, in press
28.[AUC]
29. Lampert, R: Managing with Pacemakers and ICDs, Circulation, 2013, in press (review)
30. Lampert, R: Is Electricity Useful when the Pump is Failing? More Data Urgently Needed, JACC,
2013, in press (editorial)
3) Published abstracts
1. Lampert R, Rosenfeld L, Batsford W, Lee F, McPherson C: Circadian Variation of Sustained
Ventricular Tachycardia in Patients with Coronary Artery Disease and Implantable CardioverterDefibrillators. PACE 1994; 17:834.
2. Lampert R, Rosenfeld L, VanZetta A, Lewis R, McPherson C, Batsford W, for the CPI PRXII
Investigators: Initial Multicenter Experience with a New Third-Generation Cardioverter-Defibrillator,
the CPI PRxII. PACE 1995; 18:889.
3. Lampert R, McPherson CA, Lewis RJ, Batsford WP, Rosenfeld LE: Inappropriate Sensing of Atrial
Stimuli in Patients with a Third Generation Defibrillators and DDD Pacemakers. J Am Coll Cardiol
1996; 27:348A.
4. Lampert R, Denner A, Sreenivasan D, Rosenfeld L, Lee R: Diurnal Variation of Heart Rate Fractal
Dimension in Heart Disease Patients. J Am Coll Cardiol 1996; 27:95A.
5. Lampert R, Jain D, Burg M, Batsford W, McPherson C: Effects of Mental Stress on Ventricular
Arrhythmias in Patients with Ventricular Tachycardia and Implantable Defibrillators. Circulation 1996;
94:I-568
6. Lampert R, Ickovics J, Viscoli C, Rosenfeld L, Horwitz R, Lee F: The Effect of Beta-blockers on
Recovery of Heart Rate Variability in the Beta-Blocker Heart Attack Trial (BHAT). J Am Coll Cardiol
1997; 29:176A.
7. Lampert R, Denner A, Rosenfeld L, Lee FA: Diurnal Change in Fractal Dimension Differs Between
Heart Disease Patients and Normal Individuals. PACE 1997; 20:1157.
8. Lampert R, Ickovics J, Viscoli C, Rosenfeld L, Horwitz R, Lee F: Inter-relationship between Effect
on Heart Rate Variability and Effect on Outcome by Beta-blockers in the Beta-Blocker Heart Attack
Trial (BHAT). Circulation 1998; 98: I-80.
9. Lampert R, Clancy J, McPherson C, Rosenfeld L, Batsford W; Gender Differences in Ventricular
Arrhythmia Recurrence in Patients with Implantable Cardioverter-Defibrillators. PACE 1998; 21:910.
10. Lampert R, Jain D, Burg M, Batsford W, McPherson C; Arousal State Influences Lethal Potential of
Induced Ventricular Arrhythmias. PACE 1999; 22:749.
11. Burg MM, Malkin A, Lampert R, Jain D. Psychological factors in AICD pacing and discharge.
Psychosom Med 1999;61:126.
12. Lampert R, McPherson C, Clancy J, Rosenfeld L, Batsford W: Gender Differences in Arrhythmia
Recurrence in Patients with Implantable Cardioverter-Defibrillator and Coronary Artery Disease. AHA
5/01
13. Lampert R, Joska T, Burg, M, Batsford W, McPherson C, Jain D: Anger, Anxiety, and Physical
Stress Precipitate Ventricular Arrhythmias in Patients with Implantable Cardioverter-Defibrillators.
PACE 2002; 24: 686
14. Lampert R, Baron S, McPherson C, Lee F: Long-Reaching Effects of Terrorism: Altered Heart
Rate Variability During and After September 11, 2001. PACE 2002; 24: 630
15. Goldberger Z, Rosenfeld L, Batsford W, McPherson C, Lampert R: Combining Clinical and
Electrophysiologic Criteria Effectively Determines the Need for Dual-Chamber Device in Patients
Receiving Implantable Cardioverter Defibrillators. PACE 2002; 24: 664
16. Schreibman, Rosenfeld, McPherson, Batsford, Lampert: The utility of Procainamide challenge in
Electrophyiologic Risk Assessment. J Am Coll Cardiol 2002; 39:117A
17. Burg MM, Joska T, Lampert R, Batsford W, Jain D.: Anger, anxiety and physical stress precipitate
ventricular arrhythmias in patients at high risk. Psychosom Med 2002;64:100.
18. Lampert R, Ickovics J, Horwitz R, Lee F: Heart Rate Variability Is Depressed in Conditions of
Chronic Socioeconomic Stress. PACE, 2003; 26:1111
19. Lampert R, Burg M, Lee F, Earley C, McPherson CA, Batsford W, Soufer R: Autonomic Impact of
Shock and Anger-Reactivity in Patients with Implantable Cardioverter-Defibrillators. PACE, 2003;
26:1015
20. Lampert R, Goldberger Z, Elbel B, Batsford W, McPherson C, Paltiel AD: Cost Advantage of Dual
versus Single Chamber Defibrillator Implantation. PACE, 2003; 26:982
21. Lampert, R, McPherson CA, Clancy JF, Caulin-Glaser TL, Rosenfeld LE, Batsford WP: Ventricular
Arrythmia Recurrence and Frequency are Lower in Women Than Men with Coronary Artery Disease
and Implantable Cardiverter Defibrillators. Circulation 2003; 108:IV-386
22. Davids JS, McPherson CA, Earley C, Rosenfeld LE, Clancy JF, Lampert R: Safety of Sports and
Vigorous Exercise in Patients with Implantable Cardioverter-Defibrillators. Circulation 2003; 108:IV616
23. Davids JS, McPherson CA, Earley C, Batsford WP, Grubman E, Lampert R: Benefits of Cardiac
Rehabilitation in Patients with Implantable Cardioverter-Defibrillators. Circulation 2003; 108:IV-740
24. Vaccarino V, Lampert R, Lee F, Bremner JD, Abramson J, Murrah N, Afzal N, Cheema F, Goldberg
J: Depressive Symptoms are Associated with Reduced Heart Rate Variability in Individuals without
Coronary Artery Disease. JACC 2004; 43:120A.
25. Whang W, Albert C, Lampert R, Sears S, Conti J, Wang P, Ruskin J, Muller J, Mittleman M: A
Multicenter Study of Depression as a Predictor for Appropriate Shocks Among Patients with
Implantable Cardioverter-Defibrillators. JACC 2004; 43: 116A.
26. Lampert, R, Shusterman, V, Burg, M, Lee, F, Earley, C, Goldberg, A, McPherson, C, Batsford, W,
Soufer, R: Psychological Stress Increases Heterogeneity of Repolarization in Patients with Structural
Heart Disease and Ventricular Arrhythmias. JACC 2004; 43:140A.
27. N.E. Goldstein, R. Lampert, E.H.Bradley, J. Lynn, H.M. Krumholz. Deactivation of Implantable
Cardioverter-Defibrillators at the End of Life. Journal of the American Geriatrics Society. 2004; Vol 52,
Number 4, S4.
28. Vashist, A, Arrighi, J, Lampert, R, Burg, M, Soufer, R. Differential Impact of Parasympathetic
Withdrawal to Mental Stress Ischemia as Assessed by Noninvasive Evaluation of Myocardial Perfusion
and/or Function. Accepted, ASNC, October 2004
29. Brennan, P, McPherson, CA, Batsford, WP, Rosenfeld, L, Clancy, J, Lampert, R. QRS Width: A
Limited Predictor of Arrythmia Recurrence in Patients with CAD and ICDs. Heart Rhythm. 2004;
1:S24.
30. Vaccarino, V, Lampert, R, Lee, F, Bremner, JD, Maisano, C, Abramson, JL, Murrah, N, Cheema,
F, Goldberg, J. Heart Rate Variability, a Measure of Autonomic Dysfunction, is Associated with Insulin
Resistance. Presented, AHA 11.04
31. Lampert, R, Cannom, D, Olshansky, B: Safety of Sports in Patients with Implantable Cardioverterdefibrillators: A Survey of NASPE-Heart Rhythm Society Members. Circulation, 2004. 110:III-626
32. Stopper MM, Jain D, Burg MM, Joska T, McPherson C, Batsford W, Lampert R.
Electrophysiological characteristics of anger-triggered arrhythmias. Heart Rhythm, 2005; 2:S162
33. Mahoney T, Clancy J, McPherson C, Rosenfeld L, Batsford W, Lampert R. Ejection Fraction is a
Poor Predictor of Recurrent Arrhythmia in Patients Receiving ICDs for Primary Prophylaxis. Heart
Rhythm, 2005; 2:S244
34. Naidu, S, Shusterman, V, Howes, C, Cleman, M, O’Connor, M, Goldberg, A, Lampert, R. T-wave
amplitude is a more sensitive marker of myocardial ischemia than ST-segment changes patients
undergoing exercise stress testing. Heart Rhythm, 2006; 3:S273
35. Lampert, R, Bremner, JD, Su, S, Miller, AH, Lee, FA, Cheema, F, Goldberg, J, Vaccarino, V.
Decreased heart rate variability, a measure of autonomic dysfunction, is associated with higher levels of
inflammation as measured by IL-6. Circulation, 2006, 114: II-471
36. Lampert, R, Soufer, R, McPherson, CA, Batsford, WP, Tirado, S, Earley, C, Goldberg, A,
Shusterman, V. Implantable cardioverter-defibrillator shocks increase T-wave alternans. Circulation,
2006, 114: II-475
37. Vaccarino, V, Lampert, R, Lee, F, Bremner,JD, Su, S, Cheema, FA, Goldberg, J. Depression and
heart rate variability: Is there a common genetic pathway? Circulation, 2006, 114: II-556
38. Albert, CM, Lampert, R, Conti, JB, Chung, MK, Wang,PJ, Muller, JE, Mittelman, MA. Episodes of
anger trigger ventricular arrhythmias in patients with implantable cardioverter-defibrillators.
Circulation, 2006, 114: II-831
39. Bui, V, Huynh, M, Lampert, R. Physician management of Brugada syndrome in Vietnam. Heart
Rhythm, 2007, 4: S265
40. Lampert, R., Shusterman, V, Burg, M, Batsford, W, McPherson, C, Soufer, R. Anger, alternans, and
arrhythmia: Anger-induced TWA predicts future ventricular arrhythmias in patients with ICDs. JACC,
2008, 51:A32
41. Soufer, A, Ranjbaran, H, Graeber, B, Burg M, Liu, J, Lampert, R, Tellides, G, Collins, D, Soufer, R.
Parasympathetic withdrawal and sympathetic arousal during anger correlate with elevated endothelin-1
in patients with coronary artery disease (APS March 2008)
http://www.psychosomaticmedicine.org/misc/TotalAbstractBook.pdf
42. Hauser, RG, Maron, BJ, Kadish, A, Marine, JE, Lampert, R, Scher, DL, Biria, M, Winters, S,
Cunnane, R, Amit, K. Performance of high voltage implantable cardioverter defibrillator leads in
hypertrophic cardiomyopathy: A multicenter study. Heart Rhythm, 2008, 5:S192
43. Gravelin, LM, Remetz, M, Radford, M, Lampert, R: Use of a screening tool improves appropriate
referral for implantable cardioverter-defibrillators for primary prevention. Circulation, 2008, 118: S595.
44. Lampert, R, Burg, M, Brandt, C, Dziura, J, Liu, H, Donovan, T, Soufer, R, Jamner, L: Impact of
emotions on triggering of atrial fibrillation. Circulation, 2008: 118: S640.
45. Leubbert, J, Hammill, S, Wang, Y, Rathore, SS, Lampert, R, Krumholz, H, Hendenreich, P, Curtis,
JP: Association of implanting physician certification with complications following implantable
cardioverter-defibrillator procedures: Insights from the ICD Registry. Circulation, 2008, 118: S926.
46. Curtis, JP, Leubbert, J, Wang, Y, Lampert, R, Rathore, SS, Hammill, S, Heidenreich, P, Krumholz,
H.: Association of implanting physician certification with rates of CRT-D implantation in eligible
patients: Insights from the ICD Registry. Circulation, 2008, 118: S950
47. Dai J, Lampert R, Wilson PW, Goldberg J, Ziegler TR, Vaccarino V. Adherence to the
Mediterranean diet is associated with improved cardiac autonomic function among middle-aged men.
Circulation. 2009;119(10):e294
48. Lampert R, Salberg L, Burg M. Emotional Stress Triggers Symptoms in Individuals With
Hypertrophic Cardiomyopathy: A Survey of the Hypertrophic Cardiomyopathy Association (HCMA).
Circulation, 2009;120:S495.
49. Lampert R, Wang Y, Curtis J. Factors Influencing the Use of Higher-Tech/Higher Cost Implantable
Cardioverter-Defibrillators: Data From the NCDR ICD Registry. Circulation, 2009; 120: S437 - S438.
50. Bhatt, PS, Curtis, J, Wang, Y, Lampert, R. Impact of the Medtronic Fidelis Lead Recall on
Utilization of Implantable Cardioverter-defibrillators: Data from the NCDR ICD Registry. J Am Coll
Cardiol, 2010; 55: A14.
51. Razak, E, Buncova, M, Shusterman, V, Winter, B, Shen, W, Ackerman, M, Donovan, T, Lampert, R,
Nemec, J. Slow QT interval adaptation to heart rate change in normal ambulatory subjects. Heart
Rhythm, 2010; 7: S174
52. Yuhas, J, Mattocks, K, Gravelin, L, Remetz, M, Foley, J, Fazio, R, Lampert, R. Patient attitudes and
perceptions of implantable cardioverter-defibrillators: Potential barriers to appropriate primary
prophylaxis. Heart Rhythm, 2011;
53. Rajeswaran, Y, McNamara, RL, Curtis, J, Lampert, R: Identification of Potential Candidates for
Implantable-Cardioverter-Defibrillators (ICDs) for Primary Prevention via Echocardiography Screening.
QCOR, 2011
54. Lampert, R, Tuit, K, Sinha, R: Chronic stress and adverse life events are associated with depressed
autonomic function as measured by heart rate variability. Presented AHA, 2011
55. John A. Dodson, Jeptha P. Curtis, Yongfei Wang, Stephen C. Hammill, Paul Varosy, and Rachel
Lampert Temporal trends in quality of care among ICD recipients: Insights from the NCDR ICD
Registry J Am Coll Cardiol 2012 59: E581
56. Dodson JA, Fried T, Van Ness PH, Goldstein N, Lampert R. Preferences for deactivation of
implantable cardioverter defibrillators in the setting of advanced illness (oral presentation). AGS 2012.
57. Mandawat, A, Curtis, JP, Njike, V, Lampert, R; Safety of pacemaker implantation in nonagenarians.
Presented QCOR 2012
58. Russo, AM, Wang, Y, Curtis, J, Al-Khatib, S, Lampert, R. Contemporary Patterns of Practice and
Characteristics of Patients undergoing Defibrillation Testing versus those who do not undergo Testing at
the Time of Initial ICD Implant: Analysis of the NCDR ICD Registry (presented ACC 2012)
59. Russo, R, Costa, HS, Doud, D….Lampert, R…Arsha, A. Determining the Risks of MRI at 1.5 Tesla
for Patients with Pacemakers and Implantable Cardioverter-Defibrillators. Presented AHA, 2012
60. Russo, AM,…Lampert, R. Gender and Outcomes following primary prevention ICD placement:
Analysis of the NCDR ICD Registry. Presented AHA 2012
61. Russo, AM….Lampert, R. Predictors of high defibrillation energy requirements: Results from the
NCDR ICD Registry. Presented AHA 2012
62. Rosman, L., Cutitta, K., Ford, J., Derian, L., Cahill, J., Lampert, R., Mosesso, V., N., Lawless, C., &
Sears, S., F. (July, 2013). Sex differences in prodromal symptoms of sudden cardiac arrest and
long-term psychosocial adjustment: The unmet needs of female survivors. The Society for
Women's Health Research Meeting, What a Difference an X Makes: The State of Women's
Health Research, Washington, DC.
Invited Lectures:
5/30/13, Indianapolis, IN, American College of Sports Medicine (ACSM) symposium speaker, “Is it safe
for patients with ICDs to participate in sports?”
5/9/13, Denver, CO, HRS, symposium speaker, “Safety of sports for patients with ICDs”
5/10/13, Denver, CO, HRS, symposium speaker, “When is it appropriate to turn off ICD therapies in a
terminally ill patient”
5/11/13, Denver, CO,HRS, “meet the experts”, “Optimizing identification of primary prevention ICD
candidates”
3/9/13, San Francisco, CA, ACC, symposium speaker, “Treatment options for atrial fibrillation: Are
there differences for the active patient?
3/11/13, San Francisco, CA, ACC, symposium speaker, “Does my dynamic 83 yo HFREF patient need
an ICD”
2/9/13, San Diego, CA, St Jude Medical “Women in EP Symposium”, “Clinical research on treatment
options for SCA in young athletes”
12/7/12, Los Angeles, CA, Cedar Sinai Arrhythmia Symposium, “Implantable cardioverter defibrillators
and end of life issues”.
11/5/12, Los Angeles, CA, AHA, session chair, “Controversies in ICD Management: Lead Advisories,
MRI, DFTs”
10/17/12, Kunming, China, Chia Fellowship Conference, “Chronic stress and chronic disease”
10/19/12, Kunming, China, Kunming Medical University Internal Medicine Grand Rounds, “Mental
stress and sudden cardiac death”
9/10/12, Seattle, WA, Heart Failure Society of America (HFSA), “Management of cardiac devices in
nursing homes”
8/19/12, Kansas City, MO, Kansas City Heart Rhythm Symposium, “Mental stress and ventricular
arrhythmias: the mind-body connection”
5/9/12, Boston, MA, HRS, Symposium speaker, “When to deactivate a cardiac rhythm device”
5//10/12, Boston, MA, HRS, session chair and speaker, “meet the experts” “When ICD issues are not
black and white”
11/14/11, Orlando, Fla, AHA, “Who and How should Cardiac Implantable Electronic Devices be
Deactivated?”
10/11/11 San Diego, CA, Medtronic “Women in EP” conference: Deactivation of Implantable Devices
at Patients’ End of Life
5/5/11, San Francisco, CA, HRS, panelist, “HRS Policies on Relationships with Industry”
5//11, San Francisco, CA, HRS, session chair, “The latest in ICD lead and generator technology”
5/6/11, San Francisco, CA, HRS, session chair, “Defibrillation testing: a necessity or just risky?”
4/3/11, New Orleans, LA, ACC, “Clinical cardiology spotlight: Real world cases in sports cardiology”,
panelist
4/411, New Orleans, LA, ACC “meet the experts”, “My patient wants me to turn off their cardiac rhythm
device”, session chair
10/18/10, Washington, DC, NIH/NCCAM series, “Psychological Stress and Sudden Cardiac Death”
10/2/10, Miami, Florida, Medtronic “Women in EP” conference: “Gender Bias in Device Implantation”
9/14/10, Atlanta, Georgia, National Hospice and Palliative Care Organization 11th Clinical Conference,
“Deactivation of Cardiac Rhythm Devices at Patients’ End of Life”
5/13/10, Denver, CO, HRS, “Gender differences in ICD therapy: Does bias exist?” (core curriculum)
5/14/10, Denver, CO, HRS, “It is always appropriate to turn off a CIED if requested by a competent
patient (protagonist)”, debate
3/13/10, Atlanta, GA, ACC CCCOA (council on cardiovascular care for older adults) symposium: “An
87 year old woman with arrhythmia: the patient-centered perspective”
3/15/10, Atlanta, GA, ACC, “meet the experts”, “Evaluating arrhythmias in athletes”
3/15/10, Atlanta, GA, ACC, “Psychology of cardiac arrhythmias”
9/19/09, Los Angeles, CA, Boston Scientific program, Women In EP, “Athletes and arrhythmias”
9/13/09, New York, NY, Boston Scientific program, Advanced Forum for Heart Failure and EP,
“Athletes and arrhythmias”
6/22/09, Berlin, Germany, Europace (European Heart Rhythm Association Scientific Sessions),
“Deactivating the ICD, Ethical Considerations, US Viewpoint”
6/22/09, Berlin, Germany, Europace, “Effectiveness of anti-arrhythmic therapy in females”
6/23/09, Berlin, Germany, Europace, “Mechanisms of atrial fibrillation in athletes”
5/13/09, Boston, MA, Heart Rhythm Society, Symposium, “Management of cardiac devices at patients’
end of life: Why is this an issue to be addressed?”
1/9/09, Washington, DC, Medtronic sponsored conference, Women Physicians in Electrophysiology,
“Athletes and ICD therapy: An update on the ICD Sports Registry”
7/27/08, Toronto, 14th World Congress on Heart Disease, “Role of psychological factors in triggering
ventricular arrhythmias”
5/15/08, San Francisco, CA, Heart Rhythm Society, core curriculum, “Use of the NCDR ICD Registry
Data to Evaluate Practice Patterns”
5/16/08, San Francisco, CA, Heart Rhythm Society, debate (protagonist), “Young persons with ICD for
primary prevention can participate in non-contact competitive sports”
3/13/08, Baltimore, MD, American Psychosomatic Society Scientific Sessions symposium:
“Psychological Stress and Arrhythmogenesis”.
2/9/08, Washington, DC, American College of Cardiology Symposium, “The Heart of Women’s
Health”, speaker, “Are ICDs as effective in women?”
12/13/07, Boston, MA, ICD Lead Performance Conference, Beth Israel Medical Device Institute,
speaker and panelist, “Clinical Management and Communication of ICD Lead Performance Issues”
11/ 7/07, Orlando, Florida, American Heart Association Scientific Sessions “symposium”: “How to
discontinue cardiac devices at end-of life”
5/12/07, Denver, CO, Heart Rhythm Society “core curriculum”: Device Recalls: Overreaction or LevelHeaded Decision-Making?
5/10/07, Denver, CO, Heart Rhythm Society “meet the experts”: Triggers of arrhythmia: Ischemia,
Exercise, and Emotions
5/4/07: Hartford, CT, Hartford Hospital Cardiology/Exercise Physiology Journal Club, “Safety of Sports
for Patients with ICDs”
3/26/07: New Orleans, LA, American College of Cardiology, “meet the experts”, “Cardiac rhythm
devices: Regulatory issues”
11/11/06, Chicago, Ill, American Heart Association, Heart Disease in Women Symposium, “ICD use
and effectiveness in women”
11/11/06, Chicago, Ill; PRICE symposium (Society for Geriatric Cardiology), “End of Life Care: When
to disable implanted devices”
10/13/06, Chicago, Ill, Cook County Hospital Internal Medicine Grand Rounds, “Implantable
cardioverter-defibrillators: Expanding indications and technologies
5/19/06, Boston, MA, Heart Rhythm Society, “meet the experts”, “The 36th Bethesda conference
guidelines: what the clinician needs to know”
5/19/06, Boston, MA, Heart Rhythm Society, core curriculum, “Communicating uncertainties and
complexities with patients [re device performance]”
5/18/06, Boston, MA, Heart Rhythm Society, “meet the experts luncheon”, “Cardiovascular screening
for sports participation”
5/17/06, Boston, MA, Heart Rhythm Society, panelist, “Town Hall on Device Performance”
3/06, Atlanta, GA, American College of Cardiology, core curriculum, “Psychological aspects of
implantable cardioverter-defibrillator therapy”
11/14/05, Dallas, Tx, American Heart Association, “Meet the experts luncheon”, “Sports participation
for the athlete with cardiovascular disease and an implantable device”
10/08/05, Chicago, Illinois, Medtronic-sponsored conference “Women in Heart Failure”, debate, “All
patients receiving cardiac resynchronization therapy should receive an ICD”
9/16/05, Washington, DC, Heart Rhythm Society Policy Conference on Pacemaker and ICD
Performance, speaker, “Role of the physician in device surveillance”
3/22/05, University of Pittsburgh, Pittsburgh, PA, Cardiology Grand Rounds, “Sudden death at the
casino: Psychological stress and arrhythmias”
3/7/05, Orlando, Florida, American College of Cardiology, symposium speaker, “Quality of life after
device placement”
1/28/05, Emory University, Atlanta, Georgia, Cardiology conference “Psychological stress and
arrhythmias”
10/27/04, Middletown, CT,: Atrial Fibrillation Roundtable, panelist, CT chapter ACC
5/2001: Boston, MA, North American Society of Pacing and Electrophysiology “Right Ventricular
Outflow Tract Tachycardia”.
11/1999: Atlanta, Georgia, American Heart Association “How to Manage Atrial Fibrillation in
the Elderly”
Yale Cardiology International Symposium; “Update on ICDs” 9/30/99, 10/14/99, 10/26/99
Yale International Symposium on Contemporary Management of the Cardiovascular
Patient-10/15/97 and 10/22/97
8/12/97, New Haven, CT, Pilot Pen Course: “Role of Pacing in Atrial Fibrillation”-
Other Media presentations/publications
9/18/09: New Haven, CTV “One World Progressive Institute 21st Century Conversations”: “Sudden
Cardiac death”
Lampert, R: Mental Stress and Ventricular Arrhythmias; CCACC electronic newsletter, 4.18.07
5/17/07, New Haven, CTV “One World Progressive Institute 21st Century Conversations”: “Women,
and Heart Disease”
5/8/2008, New Haven, CTV “One World Progressive Institute 21st Century Conversations”: “Women,
Stress, and Heart Disease”
Program committee, session chair
Toronto, 14th World Congress on Heart Disease, program committee
7/27/08, Toronto, 14th World Congress on Heart Disease, session chair, “Arrhythmias I”
Session chair
5/13/09, Boston, MA, Heart Rhythm Society, Symposium, Management of cardiac devices at patients’
end of life
5/16/09, Boston, MA, Heart Rhythm Society, core curriculum,
5/13/10, Boston, MA, HRS, “expert commentator”, session “Advances and Insights into health policy
and education”
5/14/10, Denver, CO, Heart Rhythm Society, “Expert consensus on management of cardiac devices at
patients’ end of life”
Research Support
Ongoing
1R01HL89340-01 (Lampert, PI)
25%
T-wave alternans and emotion in daily life
5/1/08-5/30/13
The goals of this study are to evaluate whether T-wave alternans measured via 24-hour ambulatory ECG
is associated with emotion states as assessed by experience sampling, and whether these changes
correlate with increased arrhythmia risk, in patients with ICDs.
Industry Funded/Investigator Initiated
Guidant, Medtronic, St. Jude
“ICD Sports Safety Registry”
(Lampert, PI,)
5%
1 R01 HL071116-01 (Soufer PI)
5%
NIH National, Heart, Lung and Blood Institute
"CV Responses to Mental Stress: Mechanistic Considerations"
2006-2014
9/15/08-9/14/12
This study is evaluating mechanisms of mental-stress induced ischemia. As co-investigator, my role is
analysis of heart-rate variability, with the overall goal of determining the role of autonomic nervous
system in the pathway from emotion to CNS to heart.
Interdisciplinary Research Consortium (Sinha PI) 5%
Human Subjects Core (P30)
Interdisciplinary Research Consortium (Potenza PI) 5%
fMRI of Stress & Self-Control in Smoking & Obesity
9/30/07 - 09/29/12
9/30/07 - 09/29/12
As co-investigator on this project, my role is analysis of heart rate variability, towards the goal of
evaluating whether addictive disorders alter autonomic nervous system function.
1R01HL084438-01A1 (PI, Matthew Burg, PhD,)
20%
NIH/NHLBI
Reducing Vulnerability to ICD Shock Treated Ventricular Arrhythmias
9/1/07-8/30/1
This recently-funded study will randomize patients receiving ICDs to receive stress reduction therapy
versus usual care to determine whether SRT will reduce occurrence of potentially life-threatening
arrhythmias. A co-investigator, my role is to oversee all medical aspects of this study.
1R01HL089314-01 (PI, Levy)
10%
Racial disparities in heart attach recovery: Role of stigma and stress
7/1/08-6/30/12
The goal of this study is to evaluate the role racial and age stigma in recovery after myocardial
infarction. My roles are to provide consultation and coordination regarding cardiac clinical care,
overseeing all medical aspects of the study, and to perform heart rate variability analysis, to evaluate the
role of the autonomic nervous system in any associations seen.
1 U34 HL105285-01 (PI, Yaggi)
5%
Sleep Apnea in TIA: Reducing Vascular Risk with AutoPAP (“SLEEP TIGHT”).
2R01HL068630-06A2 (PI, Vaccarino)
Mechanisms Linking Depression to Cardiovascular Risk
5%
9/10-8/15
8/17/09 - 7/31/11
As co-investigator on this project, now funded for continuation, my role is analysis of heart rate
variability, towards the goal of evaluating whether depression alters autonomic nervous system function
now being investigated prospectively.
02/07/2011 –
1R01HL102084-01A1 (PI, Goldstein)
consultant
01/31/2016
An Intervention to Improve Conversations About ICD Deactivation
My role as a consultant on this project is to provide advice regarding defibrillator functions and the
logistics of working with ICD patients
Completed
SDG 0030190
Lampert, R. (PI)
American Heart Association
Scientist Development Grant
“Mental Stress and
Ventricular Arrhythmias”
1/2000-1/2004
direct costs 260,000
This goal of this study is first, to evaluate, whether mental-stress reactivity is predictive of arrhythmia
recurrence in patients with implantable cardioverter-defibrillators, and second, to evaluate potential
mechanisms of stress-induced arrhythmia.
1R01 HL68630-01 Vaccarino (PI)
NIH/NHLBI.
"Mechanisms Linking Depression
to Cardiovascular Risk”
Lampert, R. (Co-Investigator)
(10%)
06/01/2001-05/31/2006
As co-investigator on this project, my role is analysis of heart rate variability, towards the goal of
evaluating whether depression alters autonomic nervous system function.
1R01 HL073285-01A1 (Lampert, PI)
NIH/NHLBI
“Emotional reactivity: A trigger of
Atrial Fibrillation”
25%
05/01/04-04/30/09
direct costs 1,250,000
The goals of this study are to evaluate first, whether, emotional states can trigger atrial fibrillation, and
second, whether stress-reactivity is a predictor of recurrent events, in patients with a history of atrial
fibrillation
Industry Sponsored (Lampert, PI,)
1%
Medtronic
Patient barriers to primary prevention ICD implantation
2009-10